Results from four AZD1222 (ChAdOx1 nCoV-19) vaccine trials for COVID-19

Trial Identifier: AZD1222 (ChAdOx1 nCoV-19)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
Plain Language Summary of the Lancet journal article focusing on results of 4 trials of the AZD1222 vaccine used to prevent COVID-19 disease caused by the SARS-CoV-2 virus

Trial Locations

No locations posted.